|
V.TLT
|
I know some of you are fairly insightful about this industry. This question...
|
|
V.TLT
|
All this does it take it back into a previous long-time price range so far...
|
|
V.TLT
|
Looks like either they forgot pre-market, or there was a glitch in the news...
|
|
V.TLT
|
If Roger was in charge of what the share price does, we'd have been at $2...
|
|
V.TLT
|
Maybe because it relates to the already existing 'enhances cancer drug...
|
|
V.TLT
|
Any idea why they didn't hit the typical wires with this NR and only on...
|
|
V.TLT
|
Another 'perk for Merck' could be that this is a way stay out in...
|
|
V.TLT
|
@Lesalpes, I'm not an industry expert like some of the others, but I can...
|
|
V.TLT
|
True, it's holding up better so far than it usually does. But look at the...
|
|
V.TLT
|
It has. It hit a high of .21 a couple days ago, no? Now it's .19 but to...
|
|
V.TLT
|
Well Ok then, I get what you're insunuating. I must admit I like your...
|
|
V.TLT
|
@CS & Eog, great points, thanks. Yet here we are, the market has called...
|
|
V.TLT
|
Yeah, it's hard to imagine them announcing it before doing so. I wonder...
|
|
V.TLT
|
So now will Merck say 'Hey thanks for the tip... we'll tweak BCG on...
|
|
V.TLT
|
Goosey, You might have just made a key point. I'm sure they know they...
|
|
V.TLT
|
Same thoughts here re: it makes sense that they had to have been sitting on...
|
|
V.TLT
|
Edit to my comments: I mean market credibility. I wasn't referring to the...
|
|
V.TLT
|
Is it possible that this company simply won't be assigned credibility...
|
|
V.TLT
|
Dr Lbiati needs to schmooze the big pharma execs... fancy dinners, sporting...
|
|
V.TLT
|
I do like their flexiblity with this news. It's almost like saying... Ok,...
|